Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
5036	Peter: I have some options on AGPH, Calls@25 and wonder how this action may af	billkirn	-	7/30/1998
5035	Vector: My sense is the speculation bubble is gone. I would not put a dime int	billkirn	-	7/30/1998
5034	Rick....<<Do you honestly believe that, if $20 worth of cash, patents an	billkirn	-	7/30/1998
5033	Peter, I'm interested in the answer on the options as well. Let us know wh	Peter Singleton	-	7/29/1998
5032	Entremed has a higher nominal share price than Agouron, but less than 40% as ma	John Metcalf	-	7/29/1998
5031	I'm still wondering what will become of my call options after the division	Peter Church	-	7/29/1998
5030	It is good karma for a medical stock to have MD in its stock symbol.	David S.	-	7/29/1998
5029	OK. Then why is ENMD stock price higher than AGPH's?	Izzy	-	7/29/1998
5028	<<Not enough analysts to follow companies, and therefore one shouldn'	Vector1	-	7/29/1998
5027	The stock is probably up because of a a big videoconference held at John Hopkin	margie	-	7/29/1998
5026	Bill, << I think the reason behind this attitude is, not enough analyist	Peter Singleton	-	7/29/1998
5025	Bill: Not enough analysts to follow companies, and therefore one shouldn't	scaram(o)uche	-	7/29/1998
5024	Peter: I think the reason behind this attitude is, not enough analyists to fol	billkirn	-	7/29/1998
5023	>> how could these guys have so much information, including inside inform	scaram(o)uche	-	7/29/1998
5022	Bill: I posted only what Von Emster had said at the meeting. I didn't wan	scaram(o)uche	-	7/29/1998
5021	Bill, <<got the impression he is ditching all small, under 100m, biotech	Peter Singleton	-	7/29/1998
5020	Rick: Also saw Kurt. Sat next to his wife. She said he has been shorting, an	billkirn	-	7/29/1998
5019	Nice uptrend since yesterday. Is there some news? it	Intel Trader	-	7/29/1998
5018	One big pill. A worthy idea, but it usually doesn't work, for many reasons	tommysdad	-	7/29/1998
5017	ALL, as Rick and I alluded to several posts ago (? few mos ago), and from what	Izzy	-	7/29/1998
5016	I understand. Sorry about the misunderstanding.	sam	-	7/29/1998
5015	One of the biggest complaints from HIV patients is "pill burden." So	ALL	-	7/29/1998
5014	sam: While I share your sentiment, that's not what I said and not what he	scaram(o)uche	-	7/29/1998
5013	Selling AGPH to buy VRTX BECAUSE of VRTX's second and third generation P.I.	sam	-	7/29/1998
5012	sam: Do you mean the rit/crix (400/400) studies and the ilk? Allows for bid,	scaram(o)uche	-	7/29/1998

Go to reply# or date (mm/dd/yy):